Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.041 | 0.4 |
mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |